HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

BJJF078

a transglutaminase 2 inhibitor

Also Known As:

(3,4-dimethoxy-N-(5-(4-(acryloylamino)piperidine-1-sulfonyl)-naphthalen-1-yl)-benzamide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Bol, John G J M: 1 article (01/2018)
2.	Brevé, John J P: 1 article (01/2018)
3.	Chrobok, Navina L: 1 article (01/2018)
4.	Drukarch, Benjamin: 1 article (01/2018)
5.	El Alaoui, Said: 1 article (01/2018)
6.	Jongenelen, Cornelis A: 1 article (01/2018)
7.	Wilhelmus, Micha M M: 1 article (01/2018)
8.	van Dam, Anne-Marie: 1 article (01/2018)

Related Diseases

1.	Inflammation (Inflammations) 01/01/2018 - "We found, that ERW1041E but not BJJF078 resulted in reduced EAE disease motor-symptoms while neither caused apparent changes in pathology (cellular influx), Transglutaminase activity or expression of inflammation related markers in the spinal cord, compared to vehicle treated controls. "

Related Drugs and Biologics

1.	Transglutaminases
2.	ERW1041E